KRUG INTERNATIONAL CORP
10-Q, EX-27, 2000-11-09
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: KRUG INTERNATIONAL CORP, 10-Q, EX-10.1, 2000-11-09
Next: PROVIDENT INSTITUTIONAL FUNDS, 497, 2000-11-09



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF KRUG INTERNATIONAL CORPORATION FOR THE SIX MONTHS
ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-END>                               SEP-30-2000
<CASH>                                           7,049
<SECURITIES>                                         0
<RECEIVABLES>                                    4,525
<ALLOWANCES>                                       (78)
<INVENTORY>                                      2,625
<CURRENT-ASSETS>                                14,907
<PP&E>                                           9,744
<DEPRECIATION>                                  (5,960)
<TOTAL-ASSETS>                                  20,650
<CURRENT-LIABILITIES>                            9,758
<BONDS>                                          1,606
                            2,488
                                          0
<COMMON>                                             0
<OTHER-SE>                                       5,801
<TOTAL-LIABILITY-AND-EQUITY>                    20,650
<SALES>                                         13,913
<TOTAL-REVENUES>                                13,913
<CGS>                                           12,979
<TOTAL-COSTS>                                   14,504
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 112
<INCOME-PRETAX>                                   (493)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                               (493)
<DISCONTINUED>                                    (310)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (803)
<EPS-BASIC>                                      (0.16)
<EPS-DILUTED>                                    (0.16)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission